Sten Gunnar Otto Skolling

Sten Gunnar Otto Skolling

65 ans
Health Technology
Commercial Services
Finance

Profil

Sten Gunnar Otto Skolling is currently Chairman & Chief Executive Officer at Pharmor AB, Chief Executive Officer & Director at Isles of Wines AB, Chairman at Umecrine AB, Chairman at Chordate Medical Holding AB starting 2025, Director at Lipidor AB since 2020, Director at Biochromix AB, Director at Venture Cup Ost, Director at Stockholm Biotechbuilders Association, Director-Business Development at Nanexa AB since 2022, Director at RespiNor AS, Director at Bactaviva AB, Chief Business Officer at Asarina Pharma AB since 2018, and Head-Business Development at Dilafor AB. Former roles include Chief Executive Officer at KCIF Fund Management AB, Chairman at VoluSense AS, Director at Promimic AB, Director at Xspray Pharma AB, Project Director at Pharmacia Upjohn, Director-Product Pipeline & Business Development at Novozymes Biopharma Sweden AB, Non-Executive Director at BioChromix Pharma AB, Director & Head-Business Development at Umecrine Cognition AB, Director at Limone AB, Director at NeoDynamics AB, Director at OssDsign AB, Director at KD Incentive AB, Director at Modus Therapeutics Holding AB, Deputy Director at Ziccum AB, Director at Athera Biotechnologies AB, Independent Director at Moberg Pharma AB from 2025 to 2026, Project Manager at AB Wilhelm Becker, Vice President at Karolinska Development AB (Private Equity) from 2012 to 2014, Project Manager at Kabi Pharmacia, Vice President-Portfolio Management at KDventures AB from 2007 to 2012, and Chief Financial Officer at Inhalation Sciences Sweden AB. Education includes graduate degree from Royal Institute of Technology.

Postes actifs de Sten Gunnar Otto Skolling

SociétésPosteDébut
ASARINA PHARMA AB Public Communications Contact -
NANEXA AB Corporate Officer/Principal 01/01/2016
LIPIDOR AB Directeur/Membre du Conseil 01/01/2020
CHORDATE MEDICAL HOLDING AB Président 01/05/2025
Pharmor AB
Directeur Général -
Isles of Wines AB
Directeur Général -
Bactaviva AB
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Stockholm Biotechbuilders Association
Directeur/Membre du Conseil -
░░░░░░░ ░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░ ░░░░░░░░░░ -

Anciens postes connus de Sten Gunnar Otto Skolling

SociétésPosteFin
░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Voir l'expérience en détail de Sten Gunnar Otto Skolling

Formation de Sten Gunnar Otto Skolling

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

66

Relations au 1er degré

35

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées35

Health Technology

Process Industries

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Kabi Pharmacia

Pharmacia Upjohn

Commercial Services

KCIF Fund Management AB

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Venture Cup Ost

Health Technology

Health Technology

KD Incentive AB

Health Technology

Stockholm Biotechbuilders Association

Health Technology

Electronic Technology

Health Technology

Pharmor AB

Health Technology

Isles of Wines AB

Bactaviva AB

  1. Bourse
  2. Insiders
  3. Sten Gunnar Otto Skolling
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇